Metaphore Biotechnologies, in collaboration with Flagship Pioneering, announced a research partnership with Novo Nordisk to develop up to two next-generation therapeutics for obesity management.

focusing on obesity and metabolic dysfunction-associated steatohepatitis (MASH), as well as a tie-up with Metaphore Biotechnologies for a pair of weight-loss programmes that could be worth up to ...